Efficacy analysis of carvedilol in treatment of chronic heart failure
Junwei Liu
Abstract
Junwei Liu
Abstract
Objective To observe the clinical therapeutic effect and safety of carvedilol in the treatment of chronic heart failure. Methods Sixty -eight cases of patients with chronic CHF were randomly divided into two groups:one group was received routine treatment (digitalis, diuretics, vasodilator, ACEI), and another group was received carvedilor (25 nag, bid × 90 d)as well as routine treatment. Results The treatment, efficiency in carvedilol group and control group were respectively 91.3% and 65.2% with significent difference between two groups, P <0. 01). No adverse reactions associated with carvedilol were observed. The improvements of HR, BP, LVEF, EDV, ESV after treatment in carvedilol group were significant (P < 0. 01 orP < 0. 05). Conclusions Adding carvedilol based on the routine therapy can improve the effect and the heart function. Carvedilol is a safe and effective drug. Key words: Carvedilol; Chronic congestive heart failure; β adrenoceptor bloker
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To observe the clinical therapeutic effect and safety of carvedilol in the treatment of chronic heart failure. Methods Sixty -eight cases of patients with chronic CHF were randomly divided into two groups:one group was received routine treatment (digitalis, diuretics, vasodilator, ACEI), and another group was received carvedilor (25 nag, bid × 90 d)as well as routine treatment. Results The treatment, efficiency in carvedilol group and control group were respectively 91.3% and 65.2% with significent difference between two groups, P <0. 01). No adverse reactions associated with carvedilol were observed. The improvements of HR, BP, LVEF, EDV, ESV after treatment in carvedilol group were significant (P < 0. 01 orP < 0. 05). Conclusions Adding carvedilol based on the routine therapy can improve the effect and the heart function. Carvedilol is a safe and effective drug. Key words: Carvedilol; Chronic congestive heart failure; β adrenoceptor bloker
Key concepts: Carvedilol, Medicine, Digitalis, Heart failure, Internal medicine, Cardiology, Vasodilation, Ejection fraction